Pharmacological inhibitors of cyclin-dependent kinases (CDKS) and glycogen synthast kinase-3 (GSK-3).

被引：0
|
作者：
Meijer, L [1 ]
机构：
[1] Ctr Natl Rech Sci, Stn Biol, Roscoff, France
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 226卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
238-COMP
引用
收藏
页码：U460 / U460
页数：1
相关论文
共 50 条
  • [21] A Noncatalytic Domain of Glycogen Synthase Kinase-3 (GSK-3) Is Essential for Activity
    Buescher, Jessica L.
    Phiel, Christopher J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (11) : 7957 - 7963
  • [22] Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis
    Ibrahim, Samar H.
    Akazawa, Yuko
    Cazanave, Sophie C.
    Bronk, Steven F.
    Elmi, Nafisa A.
    Werneburg, Nathan W.
    Billadeau, Daniel D.
    Gores, Gregory J.
    JOURNAL OF HEPATOLOGY, 2011, 54 (04) : 765 - 772
  • [23] Targeting glycogen kinase-3 (GSK-3) in the treatment if Type 2 diabetes
    MacAulay, Katrina
    Woodgett, James R.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (10) : 1265 - 1274
  • [24] Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Attenuates Hepatocyte Lipoapoptosis
    Ibrahim, Samar H.
    Akazawa, Yuko
    Cazanave, Sophie
    Bronk, Steven F.
    Elmi, Nafisa
    Billadeau, Daniel D.
    Gores, Gregory J.
    GASTROENTEROLOGY, 2010, 138 (05) : S774 - S774
  • [25] A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3β (GSK-3β) and mediates protein kinase A-dependent inhibition of GSK-3β
    Tanji, C
    Yamamoto, H
    Yorioka, N
    Kohno, N
    Kikuchi, K
    Kikuchi, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (40) : 36955 - 36961
  • [26] Constitutive activation of glycogen synthase kinase-3β correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer
    Cho, Yu Jin
    Kim, Ji Hun
    Yoon, Jiyeon
    Cho, Sung Jin
    Ko, Young San
    Park, Jong-Wan
    Lee, Hye Seung
    Lee, Hee Eun
    Kim, Woo Ho
    Lee, Byung Lan
    BMC GASTROENTEROLOGY, 2010, 10
  • [27] Constitutive activation of glycogen synthase kinase-3β correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer
    Yu Jin Cho
    Ji Hun Kim
    Jiyeon Yoon
    Sung Jin Cho
    Young San Ko
    Jong-Wan Park
    Hye Seung Lee
    Hee Eun Lee
    Woo Ho Kim
    Byung Lan Lee
    BMC Gastroenterology, 10
  • [28] Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level
    Sengupta, Amitabha
    Novak, Michal
    Grundke-Iqbal, Inge
    Iqbal, Khalid
    FEBS LETTERS, 2006, 580 (25): : 5925 - 5933
  • [29] Molecular targeted therapy for osteosarcoma using glycogen synthase kinase-3 beta (GSK-3β) inhibitors.
    Shimozaki, Shingo
    Yamamoto, Norio
    Nishida, Hideji
    Kimura, Hiroaki
    Takeuchi, Akihiko
    Kato, Takashi
    Aoki, Yu
    Higuchi, Takashi
    Minamoto, Toshinari
    Tsuchiya, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Design, synthesis and evaluation of 7-azaindazolyl-indolylmaleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors
    Ye, Qing
    Shen, Yanhong
    Zhou, Yubo
    Lv, Dan
    Gao, Jianrong
    Li, Jia
    Hu, Yongzhou
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 68 : 361 - 371
12345